CDH2 negative esophageal squamous cell carcinoma with cytotoxic T-lymphocyte signatures is a good responder subtype to definitive chemoradiotherapy

Date 29 September 2015
Event European Cancer Congress 2015
Session Basic Science/Translational Research
Topics Translational Research
Presenter Tanaka, Y.